214 related articles for article (PubMed ID: 33492541)
1. ASO Author Reflections: Additional Esophagectomy After Noncurative Endoscopic Resection Versus Upfront Esophagectomy in Patients with T1N0 Esophageal Squamous Cell Carcinoma.
Maruyama S; Okamura A; Watanabe M
Ann Surg Oncol; 2021 Sep; 28(9):4867-4868. PubMed ID: 33492541
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Is Esophagectomy Necessary after Noncurative Endoscopic Resection for Early Esophageal Squamous Cell Carcinoma?
Liu Z; Zhao J; Li Z
Ann Surg Oncol; 2021 Nov; 28(12):7160-7161. PubMed ID: 34263374
[No Abstract] [Full Text] [Related]
3. Letter to the Editor: Comparison of Outcomes Between Additional Esophagectomy After Noncurative Endoscopic Resection and Upfront Esophagectomy for T1N0 Esophageal Squamous Cell Carcinoma.
Liu Z; Li Z
Ann Surg Oncol; 2021 Dec; 28(Suppl 3):837-838. PubMed ID: 33956274
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Esophagectomy or Chemoradiotherapy, That is the Question: Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma.
Kanie Y; Okamura A; Asari T; Ishiyama A; Yoshio T; Tsuchida T; Chin K; Watanabe M
Ann Surg Oncol; 2021 Dec; 28(13):8436-8437. PubMed ID: 34115253
[No Abstract] [Full Text] [Related]
5. Author's Reply: Comparison of Outcomes Between Additional Esophagectomy After Noncurative Endoscopic Resection and Upfront Esophagectomy for T1N0 Esophageal Squamous Cell Carcinoma.
Maruyama S; Okamura A; Watanabe M
Ann Surg Oncol; 2021 Dec; 28(Suppl 3):839-840. PubMed ID: 33970373
[No Abstract] [Full Text] [Related]
6. Comparison of Outcomes Between Additional Esophagectomy After Noncurative Endoscopic Resection and Upfront Esophagectomy for T1N0 Esophageal Squamous Cell Carcinoma.
Maruyama S; Okamura A; Imamura Y; Kanamori J; Kanie Y; Takahashi K; Fujiwara D; Watanabe M
Ann Surg Oncol; 2021 Sep; 28(9):4859-4866. PubMed ID: 33420566
[TBL] [Abstract][Full Text] [Related]
7. Additional Esophagectomy Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma: is it a Reasonable Strategy?
Watanabe M
Ann Surg Oncol; 2021 Nov; 28(12):6923-6924. PubMed ID: 34309778
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: The Role of Skeletonizing en bloc Esophagectomy in Esophageal Squamous Cell Carcinoma.
Kim DJ; Kim HE
Ann Surg Oncol; 2022 Aug; 29(8):4918-4919. PubMed ID: 35419759
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: KCNJ15 Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma.
Nakamura S; Kanda M; Kodera Y
Ann Surg Oncol; 2020 Jul; 27(7):2569-2570. PubMed ID: 32166595
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Esophageal Squamous Cell Carcinoma-Still a Conundrum.
Squires MH; Salo JC
Ann Surg Oncol; 2022 Feb; 29(2):1334-1335. PubMed ID: 34674090
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Nodal Skip Metastasis Is Associated with Survival Benefit in Thoracic Esophageal Squamous Cell Carcinoma.
Yang YS; Shang QX; Yuan Y; Chen LQ
Ann Surg Oncol; 2021 Oct; 28(11):6353-6354. PubMed ID: 33543386
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Serine Protease 27 is a Novel Prognostic Indicator for Esophageal Squamous Cell Carcinoma with Preoperative Treatment.
Kataoka A; Yamada K; Kawamura YI
Ann Surg Oncol; 2021 Sep; 28(9):5382-5383. PubMed ID: 33454876
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Treatment Strategies for Locally Advanced Borderline Resectable Esophageal Squamous Cell Carcinoma.
Hong Y
Ann Surg Oncol; 2024 Feb; 31(2):896. PubMed ID: 37962739
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Response to Neoadjuvant Chemotherapy Strengthens the Prognostic Impact of Pathological Stage for Esophageal Squamous Cell Carcinoma.
Matsuda S; Kawakubo H; Okamura A; Takahashi K; Toihata T; Takemura R; Mayanagi S; Takeuchi H; Watanabe M; Kitagawa Y
Ann Surg Oncol; 2021 Dec; 28(13):8448-8449. PubMed ID: 34143335
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Using Efficacy Index to Clarify the Clinical Value of Each Lymph Node Station for Esophageal Squamous Cell Carcinoma.
Nie X; Li K; Peng L; Leng X
Ann Surg Oncol; 2023 Sep; 30(9):5866-5867. PubMed ID: 37322279
[No Abstract] [Full Text] [Related]
16. Additional Esophagectomy Following Noncurative Endoscopic Resection for Early Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Study.
Liu Z; Zhang J; Su Y; Pan J; Yang Y; Huang B; Zhao J; Li Z
Ann Surg Oncol; 2021 Nov; 28(12):7149-7159. PubMed ID: 34269944
[TBL] [Abstract][Full Text] [Related]
17. ASO Author Reflections: A Novel Station-Based Nodal Staging System for Esophageal Squamous Cell Carcinoma.
Yuan Y; Hong HG; Chen LQ
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):782-783. PubMed ID: 31605350
[No Abstract] [Full Text] [Related]
18. Close Observation versus Additional Surgery after Noncurative Endoscopic Resection of Esophageal Squamous Cell Carcinoma.
Song BG; Kim GH; Cho CJ; Kim HR; Min YW; Lee H; Min BH; Song HJ; Kim YH; Lee JH; Jung HY; Zo JI; Shim YM
Dig Surg; 2021; 38(3):247-254. PubMed ID: 33910202
[TBL] [Abstract][Full Text] [Related]
19. ASO Author Reflections: How Should We Approach Borderline Resectable Esophageal Squamous Cell Carcinoma?
Suzuki T; Okamura A; Watanabe M; Chin K
Ann Surg Oncol; 2020 May; 27(5):1518-1519. PubMed ID: 32108921
[No Abstract] [Full Text] [Related]
20. Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma: A Comparison of Outcomes between Esophagectomy and Chemoradiotherapy.
Kanie Y; Okamura A; Asari T; Maruyama S; Sakamoto K; Fujiwara D; Kanamori J; Imamura Y; Ishiyama A; Yoshio T; Tsuchida T; Chin K; Watanabe M
Ann Surg Oncol; 2021 Dec; 28(13):8428-8435. PubMed ID: 34085140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]